ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

University of Birmingham at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

University of Birmingham brings 3 presentations to ACR Convergence 2026 in Orlando. Its program covers new therapies for Sjögren's disease and who might benefit most from them, stromal targets for CAR-T cells, and a network meta-analysis of injectable treatments for lateral epicondylitis.

OrganizationACR Convergence 2026 Attendance
Universities and research institutes
A public research university in England.
Talk
Mon Nov 9
8:30am–9:00am
Part of Diagnosis and Management of Sjögren's Disease: Optimal Care in a New Era
Identifying Patients Who Might Benefit Most from New Sjögren's Disease Therapies
W415A
Sjögren’s
Talk
Tue Nov 10
8:30am–9:00am
Part of Beyond CD19: The Next Frontier in Engineered T-Cell Targets
Stromal Targets for CAR-T Cells
W204
Treatment safety

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Birmingham

Tell us what you sell and we’ll find the people at University of Birmingham most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction